Cancer-related Neutropenia

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

FDA approval · 2025-03-26
FDA Approved: STIMUFEND — Supplemental Application (Fresenius Kabi USA, LLC)
FDA approved a supplemental application for STIMUFEND (PEGFLILGRASTIM-FPGK) from Fresenius Kabi USA, LLC, expanding/confirming labeling to s…